U.S. Vaccines Market the Race Toward Long-Term Healthcare Resilience
According to Rohan Patil, who specializes in therapeutic areas, biopharmaceuticals, and healthcare market intelligence, with 5+ years of experience in market research and industry analysis, extensive research indicates strong growth opportunities in the U.S. vaccines market. The U.S. vaccines market size was estimated at USD 38.24 billion in 2025 and is predicted to increase from USD 39.88 billion in 2026 to approximately USD 58.26 billion by 2035, expanding at a CAGR of 4.3% from 2026 to 2035. His analysis highlights the growing importance of immunization programs, increasing investments in vaccine research and development, and rising demand for preventive healthcare solutions. The research also examines the competitive strategies of key industry participants, including Pfizer, Moderna, Merck & Co., GSK, Sanofi, and Johnson & Johnson, shaping the future of vaccine innovation and disease prevention across the U.S.
Last Updated : 10 June 2026
Category: Therapeutic Area
Insight Code: 6939
Format: PDF / PPT / Excel